Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis

被引:50
|
作者
Wang, Jann-Yuan [1 ]
Lee, Li-Na [2 ]
Yu, Chong-Jen [1 ]
Chien, Yin-Ju [3 ]
Yang, Pan-Chyr [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Nursing, Yun Lin Branch, Douliou City, Taiwan
关键词
culture-positive; infectiousness; smear-positive; sputum smear conversion; tuberculosis; SPUTUM SMEAR; ANTITUBERCULOSIS DRUGS; MEDICAL-CENTER; CHEMOTHERAPY; HEPATITIS; INFECTION; CULTURE; BACILLI; ADULTS;
D O I
10.1111/j.1440-1843.2009.01598.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: Persistent smear-positivity in patients with pulmonary tuberculosis has been shown to predict an unfavourable outcome. This study was conducted to identify the factors influencing time to sputum smear conversion. Methods: From July 2003 to June 2007, all patients with smear-positive and culture-confirmed pulmonary tuberculosis, who had attended a medical centre and a local teaching hospital, were identified. Factors that might have influenced time to smear conversion were investigated using time-to-event analysis. Results: Altogether 305 patients (mean age: 58.6 years) were studied. Diabetes mellitus was the most common underlying comorbidity. Eight patients (2.6%) had AIDS. After 2 months of treatment, 34 (11.1%) patients remained smear- and culture-positive. Cox proportional hazard regression analysis indicated that the presence of a cavity on CXR, smear grading and the first 2-month treatment regimen were independent factors influencing the time to sputum smear conversion. Among patients who had received isoniazid in the first 2 months of treatment, the time to sputum smear conversion in the 24 patients whose isolate showed isoniazid resistance was not different from that in the 236 patients whose isolate was isoniazid-susceptible (hazard ratio 1.061; 95% CI: 0.697-1.616). Conclusions: This analysis revealed that 11.1% of tuberculosis patients remained smear- positive after 2 months of treatment. Patients with cavitation, higher smear grading and those who had not used isoniazid, rifampicin, ethambutol and pyrazinamide continuously in the initial treatment phase had a longer time to sputum smear conversion.
引用
收藏
页码:1012 / 1019
页数:8
相关论文
共 50 条
  • [21] Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon
    Djouma, Fabrice Nembot
    Noubom, Michel
    Ateudjieu, Jerome
    Donfack, Hubert
    [J]. BMC INFECTIOUS DISEASES, 2015, 15
  • [22] Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi
    Harries, AD
    Nyirenda, TE
    Banerjee, A
    Boeree, MJ
    Salaniponi, FML
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1999, 93 (04) : 443 - 446
  • [23] Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis
    Gueler, M.
    Uensal, E.
    Dursun, B.
    Aydin, Oe.
    Capan, N.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (02) : 231 - 235
  • [24] Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon
    Fabrice Nembot Djouma
    Michel Noubom
    Jérôme Ateudjieu
    Hubert Donfack
    [J]. BMC Infectious Diseases, 15
  • [25] Analysis of chemotherapy result in new smear-positive pulmonary tuberculosis
    Cheng, S
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1147 - 1147
  • [26] True status of smear-positive pulmonary tuberculosis defaulters in Malawi
    Kruyt, ML
    Kruyt, ND
    Boeree, MJ
    Harries, AD
    Salaniponi, FM
    van Noord, PA
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1999, 77 (05) : 386 - 391
  • [27] DELAYED-HYPERSENSITIVITY AND HLA IN SMEAR-POSITIVE PULMONARY TUBERCULOSIS
    BOTHAMLEY, GH
    GIBBS, JH
    BECK, JS
    SCHREUDER, GMT
    DEVRIES, RRP
    GRANGE, JM
    IVANYI, J
    KARDJITO, T
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 106 (01) : 38 - 45
  • [28] Impact of sputum volume in the diagnosis of smear-positive pulmonary tuberculosis
    Chandra, T. Jaya
    [J]. INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2019, 9 (02) : 73 - 74
  • [29] Prevalence of smear-positive pulmonary tuberculosis in a rural district of Ethiopia
    Shargie, EB
    Yassin, MA
    Lindtjorn, B
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (01) : 87 - 92
  • [30] Sputum smear status at two months and subsequent treatment outcome in new patients with smear-positive pulmonary tuberculosis
    Salaniponi, FML
    Christensen, JJ
    Gausi, F
    Kwanjana, JJ
    Harries, AD
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (11) : 1047 - 1048